Bailard, Inc. Protara Therapeutics, Inc. Transaction History
Bailard, Inc.
- $3.8 Billion
- Q1 2025
A detailed history of Bailard, Inc. transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Bailard, Inc. holds 29,769 shares of TARA stock, worth $86,032. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,769
Previous 29,769
-0.0%
Holding current value
$86,032
Previous $156,000
19.23%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TARA
# of Institutions
65Shares Held
28.4MCall Options Held
365KPut Options Held
108K-
Janus Henderson Group PLC London, X03.79MShares$10.9 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.4MShares$9.83 Million0.3% of portfolio
-
Blackstone Inc New York, NY1.74MShares$5.04 Million0.03% of portfolio
-
Opaleye Management Inc. Boston, MA1.73MShares$5 Million2.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA1.67MShares$4.82 Million12.25% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $32.6M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...